Home
HanAll Biopharma

HanAll Biopharma Market Share Analysis for February 2026

Industry: N/A

Domainhanall.com

Year Founded1973

Employees201 - 500

Annual Revenue--

HanAll Biopharma

HanAll Biopharma (including company regionals)

hanall.com

See more website traffic and engagement information

Total visits to HanAll Biopharma's top domains

Understand HanAll Biopharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

hanall.com9.5K

See more with Sales Intelligence

Avg. visit duration in HanAll Biopharma's top domains

Analyze HanAll Biopharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

hanall.com00:00:54

See more with Sales Intelligence

Avg. pageviews on HanAll Biopharma's top domains

See how HanAll Biopharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

hanall.com3.00

See more with Sales Intelligence

HanAll Biopharma top competitors by domain

Top similar sites in February 2026, ranked by their affinity

harbourbiomed.comCompany NameHarbour BioMedEmployees51 - 200HQUnited States, Massachusetts, CambridgeAnnual revenue$25M - $50MTotal visits5.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by HanAll Biopharma

These are the website technologies, by industry, used by HanAll Biopharma top domains

Social (2)

Instagram

Email Services (1)

Microsoft Exchange Online

Mobile (1)

Meta Viewport

Multilingual (1)

Multilingual Support

More Technologies

2

See all

News & Signals from HanAll Biopharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsHanAll Biopharma Co., Ltd. partners with Immunovant, Inc..HANALL BIOPHARMA is developing Batoclimab as a treatment for various autoimmune diseases, including myasthenia gravis, thyroid eye disease, and chronic inflammatory demyelinating polyneuropathy, in collaboration with Immunovant.

NewsHanAll Biopharma Co., Ltd. partners with Turn.HanAll expands collaboration with Turn Biotechnologies through an exclusive licensing agreement for Epigenetic Reprogramming of Aging (ERA[TM]) technology, targeting ophthalmic and otic diseases.